Literature DB >> 23540090

Co-existence of HIV, active tuberculosis and aspergilloma in a single individual--a case report.

Urvinder Pal Singh1, Pooja Aneja, Kalpesh Patel.   

Abstract

Tuberculosis (TB) is a disease as old as mankind, whereas in India the first case of Human Immunodeficiency Virus (HIV) was reported in 1986. HIV and TB are so closely connected that their relationship is often described as a co-epidemic. Aspergilloma (Fungal Ball, Mycetoma) represents a saprophytic growth of aspergillus that colonizes in the preformed cavities commonly due to pulmonary tuberculosis (PTB). We report a case of HIV, active pulmonary tuberculosis and aspergilloma occurring in the same patient. Despite our best efforts, we could not lay our hands on any similar case in the medical literature.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23540090

Source DB:  PubMed          Journal:  Indian J Tuberc        ISSN: 0019-5707


  3 in total

1.  Clinical manifestations and outcomes of pulmonary aspergillosis: experience from Pakistan.

Authors:  Nousheen Iqbal; Muhammad Irfan; Ali Bin Sarwar Zubairi; Kauser Jabeen; Safia Awan; Javaid A Khan
Journal:  BMJ Open Respir Res       Date:  2016-12-16

2.  Clinical manifestations, associated risk factors and treatment outcomes of Chronic Pulmonary Aspergillosis (CPA): Experiences from a tertiary care hospital in Lahore, Pakistan.

Authors:  Waqas Akram; Muhammad Bilal Ejaz; Tauqeer Hussain Mallhi; Syed Azhar Bin Syed Sulaiman; Amer Hayat Khan
Journal:  PLoS One       Date:  2021-11-12       Impact factor: 3.240

3.  A prospective longitudinal study of chronic pulmonary aspergillosis in pulmonary tuberculosis in Indonesia (APICAL).

Authors:  Findra Setianingrum; Anna Rozaliyani; Robiatul Adawiyah; Ridhawati Syam; Mulyati Tugiran; Cut Yulia Indah Sari; Finny Nandipinto; Johannes Ramnath; Arief Riadi Arifin; Diah Handayani; Erlina Burhan; Martin Rumende; Retno Wahyuningsih; Riina Rautemaa-Richardson; David W Denning
Journal:  Thorax       Date:  2021-11-30       Impact factor: 9.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.